Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine

Psychological Medicine

Volumn 37, Issue 1, 2007, Pages 121-129

  Atmaca, Murad ^a   Yildirim, Hanefi ^a   Ozdemir, Huseyin ^a   Ogur, Erkin ^a   Tezcan, Ertan ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; CREATININE; N ACETYLASPARTIC ACID; QUETIAPINE; VALPROIC ACID; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; INFORMED CONSENT; MALE; MONOTHERAPY; NEUROANATOMY; NEUROPROTECTION; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; DRUG COMBINATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADULT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; VALPROIC ACID;

EID: 33845986004     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291706008968     Document Type: Article

References (38)

1. Bai, O., Wei, Z., Lu, W., Bowen, R., Keegan, D. & Li, X. M. (2002). Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. Journal of Neuroscience Research 69, 278-283.
2. Baxter, L. R., Schwartz, J. M., Phelps, M. E.,Mazziotta, J. C., Guze, B. H., Selin, C. E., Gerner, R. H. & Sumida, R. M. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 46, 243-250.
3. Bertolino, A., Frye, M., Callicott, J. H., Mattay, V. S., Rakow, R., Shelton-Repella, J., Post, R. & Weinberger, D. R. (2003). Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry 53, 906-913.
4. Bertolino, A., Nawroz, S., Mattay, V. S., Barnett, A. S., Duyn, J. H., Moonen, C. T., Frank, J. A., Tedeschi, G. & Weinberger, D. R. (1996). Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry 153, 1554-1563.
5. Blumberg, H. P., Stern, E., Ricketts, S., Martinez, D., de Asis, J., White, T., Epstein, J., Isenberg, N.,McBride, P. A., Kemperman, I., Emmerich, S., Dhawan, V., Eidelberg, D., Kocsis, J. H. & Silbersweig, D. A. (1999). Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. American Journal of Psychiatry 56, 1986-1988.
6. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders 86, 61-67.
7. Cendes, F., Andermann, F., Dubeau, F., Matthews, P. M. & Arnold, D. L. (1997). Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49, 1525-1533.
8. Chang, K. D., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A. & Ketter, T. (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry 53, 1059-1065.
9. Dando, T. M. & Keating, G. M. (2005). Quetiapine: A review of its use in acute mania and depression associated with bipolar disorder. Drugs 65, 2533-2551.
10. Deicken, R. F., Pegues, M. P., Anzalone, S., Feiwell, R. & Soher, B. (2003). Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. American Journal of Psychiatry 160, 873-882.
11. Drevets, W. C. (1999). Prefrontal cortical-amygdalar metabolism in major depression. Annuals of New York Academy of Science 877, 614-637.
12. Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M. & Raichle, M. E. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
13. Duvernoy, H. M. & Cabanis, E. A. (1991). The Human Brain: Surface, Three-Dimensional Sectional Anatomy, and MRI. Springer-Verlag: New York.
14. Duyn, H., Gillen, J., Sobering, G., van Zijl, P. C. & Moonen, C. T. (1993). Multisection proton MR spectroscopic imaging of the brain. Radiology 188, 277-282.
15. Gao, K. & Calabrese, J. R. (2005). Newer treatment studies for bipolar depression. Bipolar Disorders 7, 13-23.
16. Hamakawa, H., Kato, T., Shioiri, T., Inubushi, T. & Kato, N. (1999). Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Medicine 29, 639-644.
17. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23, 56-62.
18. Jenkins, B. G., Klivenyi, P., Kustermann, E., Andreassen, O. A., Ferrante, R. J., Rosen, B. R. & Beal, M. F. (2000). Non-linear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. Journal of Neurochemistry 74, 2108-2119.
19. Manji, H. K., Moore, G. J., Rajkowska, G. & Chen, G. (2000). Neuroplasticity and cellular resilience in mood disorders. Molecular Psychiatry 5, 578-593.
20. McIntyre, R. S., Brecher, M., Paulsson, B., Huizar, K. & Mullen, J. (2005). Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. European Neuropsychopharmacology 15, 573-585.
21. Moffett, J. R. & Namboodiri, M. A. (1995). Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. Journal of Neurocytology 24, 409-433.
22. Moore, G. J., Bebchuk, J. M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I. B., Faulk, M. W., Koch, S., Glitz, D. A., Jolkovsky, L. & Manji, H. K. (2000). Lithium increases N-acetylaspartate in the human brain: In vivo evidence in support of bcl-2′s neurotrophic effects? Biological Psychiatry 48, 1-8.
23. Petroff, O. A., Errante, L. D., Rothman, D. L., Kim, J. H. & Spencer, D. D. (2002). Neuronal and glial metabolite content of the epileptogenic human hippocampus. Annals of Neurology 52, 635-642.
24. +-induced apoptosis. European Journal of Neuroscience 17, 1563-1570.
25. Rajkowska, G., Halaris, A. & Selemon, L. D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49, 741-752.
26. Renshaw, P. F., Yurgelun-Todd, D. A., Tohen, M., Gruber, S. & Cohen, B. M. (1995). Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry 152, 444-446.
27. Richards, T. L. (1991). Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression and evaluating therapy. American Journal of Radiology 157, 1073-1078.
28. Sharma, R., Venkatasubramanian, P. N., Barany, M. & Davis, J. M. (1992). Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research 8, 43-49.
29. Silverstone, P. H., Wu, R. H., O'Donnell, T., Ulrich, M., Asghar, S. J. & Hanstock, C. C. (2003). Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations. International Clinical Psychopharmacology 18, 73-79.
30. Soares, J. C. & Mann, J. J. (1997). The functional neuro-anatomy of mood disorders. Journal of Psychiatric Research 31, 393-432.
31. Stoll, A. L., Renshaw, P. F., Sachs, G. S., Guimaraes, A. R., Miller, C., Cohen, B. M., Lafer, B. & Gonzalez, R. G. (1992). The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: An in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 32, 944-949.
32. Talairach, J. & Tournoux, P. (1998). Coplanar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers: New York.
33. Urenjak, J., Williams, S. R., Gadian, D. G. & Noble, M. (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience 13, 981-989.
34. Wei, Z., Bai, O., Richardson, J. S., Mousseau, D. D. & Li, X. M. (2003). Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. Journal of Neuroscience Research 73, 364-368.
35. Winsberg, M. E., Sachs, N., Tate, D. L., Adalsteinsson, E., Spielman, D. & Ketter, T. A. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 47, 475-481.
36. Xu, H., Qing, H., Lu, W., Keegan, D., Richardson, J. S., Chlan-Fourney, J. & Li, X. M. (2002). Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neuroscience Letters 321, 65-68.
37. Young, R. C., Biggs, J. T. & Ziegler, V. E. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journl of Psychiatry 133, 429-435.
38. 1H spectroscopy of the temporal lobes in schizophrenic and bipolar patients [Abstract]. In: Proceedings of the Society of Magnetic Resonance in Medicine: Twelfth Annual Scientific Meeting 3, New York, pp. 1539-1540.